autoimmun
reaction
associ
ms
involv
genet
environment
factor
murin
coronavirus
induc
mslike
diseas
human
coronavirus
hcov
attract
candid
environment
factor
involv
demyelin
patholog
previous
report
isol
basic
protein
mbp
crossreact
tcell
line
tcl
ms
patient
investig
antigen
crossreact
molecular
level
longterm
tcell
clone
tcc
deriv
ms
patient
vitro
select
mbp
proteolipid
protein
plp
hcov
strain
overal
tcc
virusspecif
specif
myelin
ag
hcovmyelin
crossreact
twentyeight
virusspecif
tcc
myelinspecif
tcc
obtain
six
healthi
donor
race
rtpcr
amplif
chain
five
ten
crossreact
tcc
confirm
clonal
sequenc
identifi
region
associ
crossreact
find
promis
implic
investig
role
molecular
mimicri
coronavirus
myelin
ms
mechan
relat
diseas
initi
relaps
ava
l
b
l
e
w
w
w
c
e
n
c
e
r
e
c
c
w
w
w
e
l
ev
e
r
c
l
c
e
yc
l
clinic
immunolog
multipl
sclerosi
ms
chronic
central
nervou
system
cn
autoimmun
diseas
character
inflamm
tcellassoci
myelin
destruct
precis
ms
etiolog
remain
unknown
appear
polygen
multifactori
potenti
involv
hla
gene
femal
hormon
environment
factor
also
thought
act
key
player
diseas
trigger
low
ms
correspond
author
fax
email
address
pierretalbot
iafinrsca
pj
talbot
concord
ident
twin
specif
pattern
worldwid
diseas
distribut
even
though
microbi
agent
consist
isol
tissu
patient
viral
infect
cn
trigger
autoimmun
respons
furthermor
exposur
infecti
pathogen
prior
puberti
appear
increas
risk
develop
ms
respiratori
tract
infect
often
preced
diseas
exacerb
sever
infecti
agent
associ
ms
direct
implic
viral
agent
never
confirm
lead
tcell
activ
virus
could
act
ms
initi
progress
although
immunopatholog
could
occur
much
later
diseas
onset
strongli
suggest
model
use
sjlj
mice
believ
viru
infect
prime
anim
develop
cn
autoimmun
may
appear
long
infect
clear
therefor
clinic
associ
viral
infect
trigger
exacerb
ms
remain
difficult
prove
poorli
understood
good
model
studi
viral
etiolog
agent
potenti
associ
autoimmun
neurolog
diseas
mous
hepat
viru
mhv
infect
cn
trigger
neurolog
diseas
similar
ms
genet
suscept
rodent
furthermor
human
coronavirus
hcov
respons
one
third
common
cold
also
neuroinvas
neurotrop
enhanc
potenti
relev
associ
neuropatholog
ms
therefor
investig
hcov
one
possibl
etiolog
agent
ms
proinflammatori
cell
reactiv
myelin
ag
consid
one
key
player
induct
perpetu
ms
primari
activ
reactiv
autoreact
cell
explain
variou
way
agindepend
activ
matur
cell
induc
dendrit
cell
could
shape
cytokin
milieu
favor
autoimmun
state
ms
superantigen
bind
given
famili
activ
nonspecif
famili
restrict
tcell
prolifer
epitop
spread
associ
collater
inflamm
bystand
activ
result
releas
autoantigen
share
determin
microb
selfpeptid
also
known
molecular
mimicri
neurotrop
neuroinvas
virus
hcov
molecular
mimicri
provid
eleg
framework
explain
crossreact
foreignag
selfprotein
may
trigger
perpetu
autoimmun
diseas
basi
appropri
genet
background
ag
present
tcr
repertoir
well
earlier
microbi
encount
moreov
sequenc
homolog
foreign
viral
selfprotein
essenti
molecular
mimicri
relev
shown
combinatori
peptid
librari
even
though
proof
molecular
mimicri
phenomenon
promot
autoimmun
patholog
human
still
controversi
involv
trigger
lyme
arthriti
borrelia
burgdorferi
associ
myelopathytrop
spastic
paraparesi
ham
tsp
infect
neuron
target
autoantibodi
suggest
furthermor
anim
model
exist
support
patholog
relev
molecular
mimicri
instanc
model
virusinfect
mice
repres
exampl
autoimmun
seem
involv
either
tmev
infect
potenti
autoreact
lymphocyt
normal
present
individu
nonactiv
state
moreov
tcellassoci
myelin
destruct
observ
associ
tcell
activ
inflamm
ms
myelinrel
ag
mbp
plp
shown
activ
tcell
line
ms
patient
furthermor
previou
work
show
peripher
tcell
line
tcl
deriv
ms
patient
control
donor
activ
hcov
myelin
ag
p
b
therefor
appear
essenti
character
crossreact
clonal
molecular
level
therefor
longterm
goal
aim
confirm
clonal
origin
antigen
crossreact
myelin
antigen
mbp
plp
common
cold
agent
commonli
found
popul
herein
show
tcc
deriv
blood
ms
patient
activ
either
viral
myelin
ag
sometim
crossreact
tcr
clone
sequenc
identifi
hypervari
region
character
tcr
recognit
establish
clonal
result
strengthen
hypothesi
possibl
coronavirusinduc
activ
tcell
autoimmun
molecular
mimicri
ms
patient
also
provid
framework
explain
ms
relaps
patient
diagnos
ms
select
prior
inform
consent
approv
experiment
protocol
institut
ethic
scientif
committe
thirtytwo
patient
recruit
random
studi
confidenti
preserv
time
patient
immun
modul
drug
least
month
prior
begin
studi
hlatyp
ms
patient
done
histocompat
laboratori
inrsinstitut
armandfrappi
laval
canada
prepar
ag
perform
describ
elsewher
briefli
human
myelin
basic
protein
mbp
prepar
normal
human
adult
brain
montreal
brain
bank
dougla
hospit
verdun
canada
puriti
monitor
sdspage
dr
mario
moscarello
hospit
sick
children
toronto
canada
gracious
provid
chromatograph
purifi
proteolipid
protein
plp
atcc
respect
propag
human
embryon
lung
cell
line
human
colorect
adenocarcinoma
cell
line
viral
ag
prepar
either
cell
cell
infect
cell
lyse
cultur
medium
three
cycl
freez
thaw
room
temperatur
follow
centrifug
harvest
viral
agcontain
supernat
viral
structur
nonstructur
protein
get
rid
cell
debri
presenc
infecti
viru
confirm
titrat
suscept
cell
control
ag
prepar
parallel
cultur
mockinfect
cell
viral
ag
prepar
uvirradi
whole
virusinfect
cell
lysat
inactiv
infecti
viru
control
ag
mockinfect
cultur
also
uvirradi
compet
nurs
staff
obtain
singl
blood
sampl
approxim
ml
control
subject
ms
patient
pbl
separ
ficollhypaqu
pharmacia
gradient
resuspend
concentr
cellsml
seed
flatbottom
plate
icn
total
volum
complet
medium
rpmi
invitrogen
uml
penicillin
streptomycin
gibco
vv
autolog
inactiv
serum
biorad
initi
tcell
clone
directli
blood
sampl
attempt
yield
low
product
clone
viral
myelin
ag
data
shown
use
pha
led
unspecif
prolifer
consid
inadequ
agspecif
tcc
requir
studi
tcl
therefor
gener
select
ag
one
plateag
mbp
plp
final
concentr
viral
ag
final
dilut
dilut
alway
made
complet
rpmi
medium
leftov
pbl
quickli
frozen
dri
ice
serv
apc
later
antigen
stimul
briefli
pbl
frozen
cellular
concentr
rang
cellsml
rpmi
uml
penicillin
streptomycin
gibco
vv
autolog
inactiv
serum
vv
dmso
biorad
biorad
day
incub
hoffmanla
roch
ad
tcl
cultur
final
concentr
uwel
day
primari
tcl
test
ag
specif
standard
prolifer
assay
agspecif
tcl
clone
day
clone
follow
limit
dilut
cellml
achiev
complet
medium
microwellterasaki
plate
icn
autolog
apc
gammairradi
rad
avoid
cellular
prolifer
pbl
prepar
describ
quickli
thaw
wash
cultur
medium
ad
terasaki
well
concentr
cell
well
either
mbp
plp
final
concentr
uvinactiv
viral
ag
final
dilut
increas
clone
effici
supplement
concentr
uwel
well
check
cell
growth
day
clone
poisson
distribut
suggest
clone
gener
less
seed
well
show
prolifer
cell
growth
monitor
character
round
clear
blast
form
tight
coloni
well
exhibit
cellular
expans
reveal
layer
adher
apc
visibl
cytoplasm
structur
cover
well
surfac
subsequ
posit
cell
growth
higher
cell
popul
acid
cultur
medium
yield
less
posit
well
per
seed
plate
presenc
irradi
autolog
apc
select
ag
mbp
plp
reach
number
cell
allow
test
antigen
specif
standard
prolifer
assay
select
tcc
test
antigen
specif
expand
stimul
select
ag
bimonthli
interv
alway
irradi
autolog
apc
maximum
four
antigen
restimul
tcc
frozen
rpmi
medium
supplement
vv
fetal
calf
serum
invitrogen
vv
dmso
sigma
ascertain
ag
specif
prolifer
assay
perform
ad
cell
per
well
round
bottom
microtit
plate
icn
irradi
apc
variou
ag
ad
separ
complet
cultur
medium
mlwell
select
ag
mbp
plp
viral
ag
uvinactiv
infect
cell
lysat
final
dilut
control
ag
use
tetanu
toxoid
appropri
dilut
uvtreat
uninfect
cell
lysat
serumfre
complet
cultur
medium
myelin
coronaviru
ag
appropri
control
respect
medium
alon
uninfect
cell
lysat
test
tcc
accord
select
ag
use
h
tritiatedthymidin
amersham
ad
h
cell
harvest
onto
glass
microfib
filter
skatron
skatron
model
micro
cell
harvest
count
ultimagold
scintil
fluid
packard
use
canberra
packard
tricarb
scintil
counter
stimul
index
si
calcul
ratio
radioact
count
per
minut
cpm
incorpor
presenc
specif
ag
cpm
control
ag
si
valu
count
higher
incorpor
cpm
consid
signific
cpm
valu
somehow
lower
usual
cpm
cutoff
use
work
tcl
sinc
sometim
lower
number
cell
use
assay
tcc
primari
tcc
frozen
futur
experiment
specif
ascertain
tcc
put
back
cultur
prior
rna
extract
avoid
clonal
exhaust
thu
frozen
tcc
thaw
quickli
cell
pellet
cell
lyse
resuspend
rna
extract
use
invitrogen
small
number
cell
use
rna
extract
glycogen
ad
precipit
step
recommend
manufactur
invitrogen
concentr
ratio
total
rna
determin
spectroscopi
nm
nm
ascertain
phenotyp
tcc
clone
result
differ
antigen
select
chosen
total
rna
extract
sampl
rtpcr
amplifi
gene
perform
sampl
total
rna
revers
transcrib
cdna
moloney
murin
leukemia
viru
revers
transcriptas
mmlv
rt
use
oligo
primer
accord
manufactur
protocol
invitrogen
briefli
sampl
put
min
revers
transcript
carri
min
total
volum
mm
dntp
mix
roch
unit
rnase
inhibitor
roch
unit
mmlv
rt
invitrogen
one
fifth
reaction
use
pcr
hot
start
min
anneal
min
follow
cycl
min
min
min
perkinelm
thermocycl
use
pharmacia
pcr
mixtur
contain
dntp
mix
genespecif
primer
genespecif
primer
amplif
gi
ttc
cca
ctc
gcc
ttt
aca
gtt
g
nt
cac
ctg
aca
cag
aag
aag
atg
cc
nt
rtpcr
follow
set
primer
use
gi
cac
caa
gaa
gtc
cac
cct
caa
g
gaa
ctc
cta
tcc
tca
aac
ccg
c
crossreact
tcc
total
rna
sampl
revers
transcrib
standard
invitrogen
kit
protocol
briefli
dephosphoryl
uncap
total
rna
sampl
rna
generac
oligonucleotid
ligat
rna
end
prior
revers
transcript
oligo
dt
strategi
allow
amplif
unknown
rna
sequenc
use
genespecif
primer
locat
constant
region
chain
primer
cct
cct
tcc
cat
tca
ccc
acc
gi
primer
correspond
rna
oligo
previous
ligat
race
rtpcr
amplif
includ
hot
start
min
anneal
min
follow
cycl
min
min
min
perkinelm
apparatu
dna
polymeras
expand
high
roch
amplicon
run
wv
agaros
gel
amplif
product
cut
gel
purifi
snap
column
invitrogen
clone
zero
topo
pcr
clone
kit
sequenc
invitrogen
topo
vector
use
standard
protocol
provid
manufactur
plasmid
dna
isol
coloni
transform
bacteria
sequenc
bio
montreal
canada
clone
bacteri
coloni
sequenc
orient
valid
molecular
clonal
tcc
diversitypcr
perform
bacteri
coloni
obtain
transform
clone
amplicon
zero
topo
vector
use
primer
specif
hypervari
sequenc
clone
combin
primer
describ
earlier
hundr
coloni
analyz
transform
tcc
region
primer
correspond
follow
sequenc
agt
cta
aat
cca
gcg
agt
tat
gg
agc
tta
agc
ctg
tat
agc
ggt
agc
agc
tta
aat
ggg
agc
cca
agc
ctc
agc
cta
tta
agc
cca
briefli
bacteri
coloni
boil
steril
water
spun
maxim
speed
tabl
centrifug
clarifi
supernat
aliquot
use
pcr
perform
previou
section
except
anneal
carri
cycl
amplicon
run
wv
agaros
gel
thirtytwo
ms
patient
select
random
design
confidenti
purpos
particip
studi
ms
affect
femal
predilect
major
femal
donor
year
old
median
age
women
men
refer
medic
file
none
treat
immunomodul
drug
least
month
prior
enrol
studi
tcell
line
tcl
gener
select
ag
clone
limit
dilut
tabl
indic
total
number
clone
tcc
obtain
tcl
show
global
distribut
monospecif
tcc
gener
ms
patient
tcc
produc
healthi
donor
tcc
respond
control
ag
tetanu
toxoid
clone
gener
ms
patient
respond
coronavir
ag
recogn
either
mbp
plp
two
myelin
ag
test
protocol
design
gener
longterm
tcc
sinc
present
achiev
purifi
protein
pool
protein
present
irradi
apc
random
sampl
tcc
test
rtpcr
data
shown
monospecif
agspecif
tcc
come
patient
could
gener
longterm
tcc
antigen
stimul
list
tabl
sampl
patient
appear
list
allow
product
longterm
tcc
determin
antigen
specif
fig
illustr
typic
prolifer
profil
cpm
stimul
index
si
obtain
highli
prolifer
tcc
establish
ms
patient
select
either
hcov
myelin
ag
cpm
valu
observ
cours
studi
state
select
ag
follow
prolifer
assay
valu
seem
indic
specif
pattern
prolifer
could
establish
given
ag
tcc
exhibit
high
prolifer
other
yield
lower
tritiatedthymidin
intak
autoantigen
mbp
plp
gener
led
lower
prolifer
count
compar
viral
ag
result
obtain
fourth
antigen
stimul
correspond
select
ag
coronaviru
ag
led
higher
absolut
measur
thymidin
intak
measur
went
beyond
cpm
howev
si
tcc
high
constant
throughout
four
antigen
stimul
period
two
month
tcc
reach
fourth
antigen
stimul
includ
overal
total
tcc
produc
experi
first
antigen
stimul
establish
tcl
second
correspond
clone
limit
dilut
third
fourth
antigen
restimul
select
ag
mostli
expans
phase
agspecif
tcc
cultur
overal
tcc
grow
third
stimul
clone
surviv
fourth
stimul
great
variabl
patient
regard
tcc
product
tabl
show
distribut
longterm
monospecif
crossreact
tcc
obtain
tcc
clone
respond
coronavir
ag
respond
ag
ag
tcc
recogn
myelin
ag
tcc
select
mbp
plp
addit
monospecif
tcc
crossreact
clone
obtain
ms
patient
inde
patient
even
lead
product
monospecif
tcc
other
gener
sever
crossreact
tcc
tabl
describ
ag
specif
coronavirusmyelin
crossreact
tcc
cn
myelin
ag
test
addit
coronavir
ag
hcovspecif
clone
vice
versa
crossreact
tcc
remain
specif
select
ag
also
respond
heterolog
ag
interest
clone
longer
recogn
select
ag
respond
heterolog
ag
observ
elimin
investig
could
repres
nonclon
popul
frequent
occurr
phenomenon
tcc
lost
reactiv
myelin
ag
select
plp
mbp
six
ten
tcc
select
viral
ag
four
two
also
prolifer
stimul
myelin
ag
interestingli
two
tcc
select
either
recogn
mbp
plp
ag
hand
two
tcc
select
plp
two
select
mbp
recogn
ag
tabl
therefor
appear
mbp
two
ag
predominantli
involv
crossreact
among
patient
abl
gener
crossreact
tcc
four
suffer
chronicprogress
cp
form
ms
two
relapsingremit
rr
form
relationship
could
observ
ms
sever
given
patient
coronavirusmyelin
crossreact
tcc
patient
crossreact
clone
deriv
hlatyp
half
tabl
repres
genet
suscept
factor
associ
ms
character
tcr
involv
crossreact
identifi
tcr
chain
tcc
variabl
tcr
region
coronavirusmyelin
crossreact
tcc
identifi
tabl
clone
analyz
chain
follow
race
rtpcr
amplif
genespecif
primer
tcc
sequenc
reaction
orient
perform
result
sequenc
present
tabl
order
get
higher
statist
signific
clonal
tcc
sequenc
diversitypcr
perform
hundr
bacteri
coloni
per
tcc
except
bacteri
clone
ingest
vector
transform
everi
bacteri
clone
analyz
pcr
produc
amplicon
expect
size
demonstr
without
reason
doubt
clonal
crossreact
cell
hlatyp
patient
tabl
analog
amino
acid
present
portion
identifi
tcr
instanc
four
five
studi
crossreact
tcc
begin
leucin
portion
also
similar
length
amino
acid
portion
ident
contain
follow
threoninearginineleucin
trl
segment
also
found
tcc
hcovmyelin
ag
crossreact
previous
report
highli
signific
fraction
tcl
ms
patient
compar
healthi
control
crossreact
could
repres
mixtur
antigen
reactiv
due
nonclon
popul
cell
clonal
proven
product
tcc
result
confirm
coronaviralmyelin
crossreact
singl
cell
level
involv
two
major
myelin
ag
mbp
plp
two
hcov
serotyp
overal
healthi
donor
ms
patient
monospecif
tcc
activ
viral
ag
tcc
respond
myelin
ag
autoreact
cell
present
healthi
individu
well
patient
autoimmun
disord
detect
autoreact
cell
monospecif
tcc
myelin
ag
normal
donor
surpris
moreov
particip
abl
get
tcc
relapsingremit
rr
form
patholog
suffer
chronicprogress
cp
ms
associ
specif
cell
prolifer
profil
note
key
featur
protocol
consist
use
stock
autolog
apc
throughout
studi
requir
singl
blood
sampl
individu
greater
flexibl
antigen
restimul
therefor
achiev
experi
independ
extern
element
like
intak
medic
possibl
fluctuat
health
patient
avoid
possibl
immun
variat
occur
ag
restimul
furthermor
autolog
apc
adequ
address
antigen
restrict
necessari
present
avoid
introduct
foreign
element
cultur
key
featur
consid
work
studi
particip
exhibit
variou
haplotyp
significantli
increas
product
tcc
agspecif
tcl
gener
evalu
vivo
frequenc
activ
tcc
thu
forbidden
sinc
lymphocyt
previous
activatedselect
vitro
natur
ag
determin
gener
tcc
even
though
known
long
time
peptid
provid
advantag
potent
antigen
stimul
allow
identif
specif
epitop
use
complet
protein
chosen
studi
increas
rang
avail
epitop
might
favor
present
conform
furthermor
shown
use
peptid
might
faith
reproduc
gener
intracellular
load
peptid
come
process
nativ
antigen
even
though
si
similar
stimul
either
coronaviru
myelin
ag
fig
coronavir
ag
better
activ
cell
nearli
tcc
select
viral
ag
tabl
common
seropos
coronaviru
popul
may
link
result
one
keep
mind
myelinreact
tcc
low
vivo
frequenc
mbp
plp
mbp
plp
ms
blood
donor
gener
longterm
primari
tcc
select
either
viral
myelin
ag
hcovmyelin
crossreact
tcc
produc
blood
ms
patient
first
number
indic
stimul
index
si
cpm
count
indic
parenthes
si
given
antigen
ratio
radioact
cpm
obtain
tritiatedthymidin
incorpor
cell
stimul
select
antigen
cpm
gener
stimul
correspond
control
antigen
tcell
clone
consid
posit
ag
cpm
count
higher
si
valu
bold
indic
select
ag
specif
tcc
antigen
specif
assay
viral
ag
test
myelin
ag
vice
versa
viral
myelin
ag
test
one
anoth
name
crossreact
tcc
bold
indic
tcc
studi
sequenc
prolifer
reach
criteria
consid
nonsignific
ns
presenc
activ
cell
reactiv
plp
cn
mice
immun
plpspecif
peptid
induc
eae
add
relev
autoreact
cell
induct
autoimmun
diseas
furthermor
relev
autoimmunolog
cell
memori
critic
factor
chronic
autoimmun
diseas
suggest
lifelong
persist
encephalitogen
cell
clone
rat
cn
longlast
persist
autoimmun
tcell
clone
mbp
plp
human
blood
memori
cell
lower
threshold
activ
therefor
activ
immun
respons
high
affin
foreign
antigen
crossreact
lowaffin
selfligand
may
potenti
reactiv
autoreact
cell
respons
anoth
interest
observ
crossreact
tcc
select
viral
ag
could
instanc
recogn
myelin
ag
clone
describ
tabl
might
underlin
fact
autoreact
tcell
ag
recognit
associ
degenerateflex
natur
tcr
essenti
good
recognit
foreign
antigen
holler
kranz
previous
propos
conform
model
possibl
mean
explain
cell
crossreact
recent
shown
crossreact
tcr
possess
molecular
flexibl
accommod
structur
divers
ligand
type
crossreact
initi
select
ag
either
viral
myelin
ag
could
potenti
patholog
signific
inde
autoreact
cell
present
healthi
individu
autoimmun
potenti
cell
appear
good
part
control
regulatori
cell
howev
regulatori
cell
impair
capac
ms
patient
autoreact
cell
easili
activ
furthermor
previous
shown
myelin
oligodendrocyt
glycoprotein
mog
autoreact
cell
isol
ms
patient
increas
cytotox
properti
compar
isol
control
subject
therefor
even
though
result
demonstr
crossreact
tcc
obtain
relev
implic
trigger
exacerb
diseas
presenc
ms
patient
control
make
plausibl
cell
play
direct
indirect
role
induc
autoimmun
vivo
regard
potenti
patholog
signific
tcc
select
viral
ag
could
activ
peripheri
coronaviru
infect
pass
blood
brain
barrier
gain
access
cn
damag
myelin
altern
tcc
select
myelin
ag
could
activ
follow
myelin
damag
result
cytopath
infect
injuri
lead
releas
autoantigen
subsequ
coronaviru
infect
occur
enhanc
maintain
induc
autoimmun
sinc
coronaviru
reinfect
possibl
could
explain
least
link
ms
relaps
cytotox
lymphocyt
attract
cn
murin
coronaviru
mhv
infect
need
help
popul
effect
clear
viru
cn
moreov
recent
demonstr
mbpreactiv
cell
activ
follow
infect
cn
therefor
cell
may
also
essenti
clear
neuroinvas
hcov
cn
could
react
myelin
epitop
expos
signific
concentr
damag
result
inflamm
brought
virusmedi
activ
glial
cell
cytokin
nitric
oxid
moreov
presenc
coronavirus
within
cn
could
increas
number
mhc
molecul
cell
surfac
could
also
particip
possibl
establish
autoimmun
state
crossreact
self
viral
antigen
recent
report
inde
crossreact
human
mbp
high
level
crossreact
myelinderiv
peptid
influenza
ha
one
specif
tcc
recent
report
repres
exampl
potenti
virusinduc
molecular
mimicri
evid
need
confirm
exampl
realli
explain
molecular
mimicri
repres
relev
explan
link
infect
human
neurolog
diseas
like
ms
degeneraci
tcell
repertoir
crossreact
activ
autoreact
cell
must
tightli
regul
therefor
molecular
mimicryrel
activ
autoreact
cell
follow
infect
would
requir
infecti
agent
encod
mimic
epitop
process
nativ
protein
moreov
pathogen
abl
induc
innat
immun
system
order
start
process
clonal
expans
potenti
patholog
crossreact
cell
may
essenti
inflamm
process
occur
target
organ
initi
maintain
put
autoimmun
reaction
model
autoimmun
diseas
resembl
ms
induc
use
recombin
theiler
murin
encephalomyel
viru
tmev
express
mimic
peptid
relat
plp
recent
report
describ
use
viru
initi
exacerb
diseas
show
requir
necessari
order
produc
diseas
demonstr
virusinduc
molecular
mimicri
inde
viabl
explan
onset
demyelin
diseas
like
ms
furthermor
infect
often
tempor
associ
relaps
ms
relaps
lead
sustain
neurolog
deficit
noninfectionassoci
relaps
even
though
still
convinc
evid
role
specif
viral
agent
initi
mainten
diseas
like
ms
virus
major
player
search
caus
multipl
sclerosi
common
one
caus
upper
respiratori
tract
infect
often
associ
ms
relaps
potenti
role
molecular
mimicri
ms
report
paper
describ
tcr
deriv
ms
patient
recogn
mbp
ebv
peptid
analysi
crystal
structur
mhcpeptid
complex
reveal
strong
degre
structur
equival
provid
structur
evid
molecular
mimicri
involv
hla
molecul
haplotyp
appear
present
immunodomin
mbp
peptid
repres
genet
factor
increas
suscept
develop
ms
known
sever
vitro
tcell
clone
tcc
gener
ms
patient
also
activ
viral
bacteri
peptid
contain
predict
motif
bind
moreov
recent
report
use
human
transgen
mice
model
overexpress
coupl
peptid
come
either
mbp
myelin
oligodendrocyt
glycoprotein
mog
msderiv
tcr
specif
describ
spontan
demyelin
diseas
strongli
resembl
ms
therefor
hlatyp
result
tabl
concord
literatur
presenc
two
tcr
distinct
chain
singl
cell
could
possibl
molecular
studi
perform
identifi
region
tcr
high
proport
tcr
chain
observ
studi
consist
literatur
indic
express
ms
patient
believ
portion
particular
beta
chain
could
favor
interact
involv
autoimmun
peptid
autoreact
lymphocyt
interestingli
identifi
one
tcc
also
associ
autoreact
myelin
tcc
associ
certain
famili
crossreact
ms
patient
interest
explor
possibl
new
geneticrel
pattern
might
lead
pathogenesi
strongli
suggest
furthermor
hypervari
portion
crossreact
tcr
identifi
may
interest
see
whether
hypervari
sequenc
crossreact
clone
could
use
molecular
probe
cn
futur
investig
requir
examin
tcrpeptid
interact
pinpoint
epitop
involv
crossrecognit
observ
howev
even
though
result
sequenc
diversitypcr
demonstr
clonal
crossreact
cell
isol
ms
patient
possibl
cell
bear
two
tcr
remain
inde
even
though
remain
uncertain
whether
tcr
differ
chain
alway
function
dual
receptor
cell
tcr
exist
type
cell
may
repres
normal
repertoir
human
mous
furthermor
least
two
import
report
shown
dual
receptor
tcell
could
express
two
fulli
function
tcr
differ
chain
therefor
dual
recognit
antigen
tcc
could
involv
either
tcr
recogn
viral
self
antigen
hla
haplotyp
two
differ
tcr
two
differ
chain
tcc
interact
two
differ
hladr
molecul
apc
nevertheless
fact
three
five
crossreact
tcc
deriv
patient
homolog
dr
haplotyp
strongli
suggest
recognit
hladr
molecul
tcc
studi
could
involv
overlap
peptid
purifiedfraction
viral
protein
assess
fine
specif
tcc
isol
studi
tcr
gene
reconstitut
fast
grow
tcell
hybridoma
could
allow
analysi
interpret
identifi
sequenc
peptid
affin
investig
confirm
whether
test
tcc
possess
one
tcr
although
sever
virus
could
involv
virusinduc
autoimmun
patholog
like
ms
human
respiratori
pathogen
like
hcov
repres
attract
candid
furthermor
interest
look
coronaviralmyelin
crossreact
neurolog
patholog
inflamm
also
key
player
coronavir
reinfect
possibl
neurotrop
neuroinvas
properti
hcov
may
explain
initi
exacerb
symptom
variou
neuropatholog
conclus
result
concern
crossreact
consist
molecular
mimicri
suggest
mechan
could
occur
relev
ms
patient
activ
singl
tcell
recogn
viral
myelin
ag
could
repres
mechan
involv
trigger
autoimmun
attack
observ
ms
amplifi
maintain
autoimmun
genet
predispos
individu
